Update from the 2013 International Neurofibromatosis Conference

Scott R. Plotkin*, Anne C. Albers, Dusica Babovic-Vuksanovic, Jaishri O. Blakeley, Xandra O. Breakefield, Courtney M. Dunn, D. Gareth Evans, Michael J. Fisher, Jan M. Friedman, Marco Giovannini, David H. Gutmann, Michel Kalamarides, Andrea I. Mcclatchey, Ludwine Messiaen, Helen Morrison, David B. Parkinson, Anat O. Stemmer-Rachamimov, Raamsdonk CD Van, Vincent M. Riccardi, Tena RosserAaron Schindeler, Miriam J. Smith, David A. Stevenson, Nicole J. Ullrich, der Vaart T van, Brian Weiss, Brigitte C. Widemann, Yuan Zhu, Annette C. Bakker, Alison C. Lloyd

*Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

Original languageEnglish
Pages (from-to)2969-2978
Number of pages0
JournalAMERICAN JOURNAL OF MEDICAL GENETICS PART A
Volume164
Issue number12
DOIs
Publication statusPublished - 2014

Keywords

  • NF1
  • NF2
  • SMARCB1
  • neurofibromatosis 1
  • neurofibromatosis 2
  • schwannomatosis
  • tumor suppressor
  • merlin
  • neurofibromin
  • preclinical models

Cite this